The Med-AI Brief
Good morning, {{first_name|Doctor}}. Last issue: most of you are using AI scribes without formal guidance. This month the guidance arrived, and a safety investigation opened a week later.
In today's Med-AI Brief:
⚖️ Regulation: MHRA says most AI scribes aren't devices
🩺 Research: the trial against usual care, and it's awkward
🌍 Use cases: South West London switches on
💼 Jobs: eight roles across the NHS, industry and academia
REGULATION
⚖️ Your scribe probably isn't a medical device
The brief: On 29 July the MHRA clarified where the regulatory line sits for ambient voice technology. A week later, on 6 August, HSSIB opened a patient safety investigation into the same technology.
The details:
Not a device: AVT that only transcribes, summarises, drafts letters or suggests codes for clinician review.
Is a device: anything supporting diagnosis, treatment or prevention, or acting automatically, such as placing an order without review.
It doesn't change the law. It states how existing regulation already applies, and it is in force now.
HSSIB covers acute adult secondary care and reports summer 2027, prompted by adoption outpacing the safety picture.
Why it matters: "Not a medical device" is not "not your problem." The exemption exists because you are the safety control. The MHRA was explicit that clinicians must verify every output. And note what flips a product into regulated territory: a vendor shipping a feature that drafts an order. That decision isn't yours; the consequence lands in your trust. Read the release notes.
RESEARCH
🩺 Two scribes, one trial, different answers
The brief: The largest pragmatic trial testing ambient scribes against usual care, published in NEJM AI, found no uniform benefit.
The details:
238 outpatient physicians across 14 specialties, randomised to DAX Copilot, Nabla, or usual care.
Nabla cut time-in-note 9.5% versus control. DAX showed no significant change.
Uptake was voluntary and low, around a third of visits in both arms. A tool used that rarely can't move the average much.
Why it matters: Time saved isn't a property of "AI scribes." It's a property of a specific product, used consistently. Two tools, one trial, different answers. If your trust is being sold on a vendor-commissioned survey (last issue's 90% figure was exactly that), this is the paper to put on the table instead.
USE CASES
🌍 South West London switches on
The brief: Kingston and Richmond began its AVT rollout in early August, joining St George's, Epsom and St Helier, and Croydon. That is the same month HSSIB opened its investigation.
The details:
Tens of thousands of staff across the group, following pilots rather than replacing them.
It sits inside NHS England's accelerating AI rollout under a £10bn technology investment.
Trusts are publishing multi-year strategies now, not pilots. Mid Cheshire has mapped AI deployment to 2033.
Why it matters: Deployment is running ahead of both the evidence and the safety review. That's an argument for local governance, not against rollout. The practical question this week: who owns AVT incident reporting in your trust, and has anyone told you how to file one?
JOBS
💼 Eight Opportunities, posted in the Health Tech Space
NHS trusts, a national body, a university and the scribe vendors themselves. All live as of this morning; NHS closing dates noted because some are tight.
NHS, public sector and academia
Chief Clinical Information Officer — Central London Community Health Trust. £103,102–£117,560. Posted 11 Aug, closes 31 Aug. Apply
Consultant in ICM & Anaesthetics, with an interest in AI research — The Royal Marsden. £113,565–£150,569. Posted 11 Aug, closes 30 Aug. Apply
Senior Data Science Manager — NHS England, national team. £66,582–£77,368. Posted 10 Aug, closes 31 Aug. Apply
Senior Research Fellow, Data Scientist / Epidemiologist — Sheffield Hallam University. £46,049–£58,225. Posted 5 Aug, closes 23 Aug. Apply
Industry
Physician Executive — Abridge, remote. $160k–$260k plus equity. Posted 3 Aug. A clinical leadership seat at an ambient scribe vendor. Apply
Senior Analytics Engineer — Accurx, London. £85k–£105k. Posted 4 Aug. Their messaging already sits in most GP practices. Apply
Staff / Senior MLOps Engineer — Corti, Copenhagen. Posted 7 Aug. Speech and agent models for clinical encounters. Apply
Senior Product Designer — Nabla, Paris. Posted 17 Aug. Yes, the scribe that actually moved the needle in today's trial. Apply
Hiring in medical AI? Reply and I'll consider it for next week.
QUICK HITS
📰 Everything else
NHS: 500,000+ staff due Microsoft 365 Copilot by October. Source
Gulf: The SFDA became the first regulator anywhere to authorise an AI app measuring heart rate, oxygen saturation and blood pressure from a phone camera. Source
Research: A JAMIA crossover trial compares two ambient scribes on burnout. Source
Regulation: EU AI Act high-risk device deadlines moved to December 2027 and August 2028.
How was today's brief?
Until next week,
Saeed
Know a colleague who'd use this? Send them your referral link.
Nothing here is clinical or legal advice. Check any tool against your own information-governance rules before it touches patient data.